CD40 Ligand Antikörper (AA 108-157)
Kurzübersicht für CD40 Ligand Antikörper (AA 108-157) (ABIN6748490)
Target
Alle CD40 Ligand (CD40LG) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 108-157
-
Marke
- IHC-plus™
-
Spezifität
- Human CD40LG / CD40L
-
Homologie
- Percent identity by BLAST analysis: Human, Dog, Bovine, Pig (100%) Mouse, Rat (83%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa108-157 of human CD40LG (P29965, NP_000065). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset, Sheep, Dog, Bovine, Bat, Horse, Pig (100%), Elephant, Rabbit (92%), Cat (90%), Galago (84%), Mouse, Rat (83%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: IHC, IHC-P (5 μg/mL), WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CD40 Ligand (CD40LG)
-
Andere Bezeichnung
- CD40LG / CD40L / CD154
-
Hintergrund
-
Name/Gene ID: CD40LG
Family: TNF
Synonyms: CD40LG, CD154, CD154 antigen, CD40-L, CD40 ligand, CD40L, gp39, HIGM1, IGM, IMD3, T-BAM, TNFSF5, CD40 antigen ligand, CD54, HCD40L, T-B cell-activating molecule, T-cell antigen Gp39, TNF-related activation protein -
Gen-ID
- 959
-
NCBI Accession
- NP_000065
-
UniProt
- P29965
-
Pathways
- NF-kappaB Signalweg, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-